Dow Jones

39,150.33

0.04%

Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

Regístrate

SRZN

Surrozen (SRZN)

Surrozen Inc

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:SRZN

1 2 3 Próxima >

Fecha	Hora	Fuente	Título	Símbolo	Compañía
12/06/2024	07:30	GlobeNewswire Inc.	Surrozen Publishes Study in ‘eLife’ Demonstrating the Promise of The Proprietary SWEETS Platform, a Unique Targeted Protein Degradation Technology, to Further Enhance Wnt Signaling	NASDAQ:SRZN	Surrozen Inc
10/06/2024	07:30	GlobeNewswire Inc.	Surrozen Presents Preliminary Results from Phase 1a Study of SZN-043 in Healthy Volunteers and Patients with a History of Liver Cirrhosis at the 2024 European Association for the Study of the Liver (EASL) in Milan	NASDAQ:SRZN	Surrozen Inc
04/06/2024	07:30	GlobeNewswire Inc.	Surrozen Initiates Dosing of First Patient in Phase 1b Clinical Trial of SZN-043 for Severe Alcohol-Associated Hepatitis	NASDAQ:SRZN	Surrozen Inc
09/05/2024	07:30	GlobeNewswire Inc.	Surrozen Presents Data Demonstrating the Promise of Antibody-Based Wnt Mimetics in Treating Cornea Endothelial Dystrophies and Dry Eye Disease at the Associations for Research in Vision and Ophthalmology (ARVO) Annual Meeting	NASDAQ:SRZN	Surrozen Inc
08/05/2024	15:05	GlobeNewswire Inc.	Surrozen Provides First Quarter 2024 Financial Results and Business Update	NASDAQ:SRZN	Surrozen Inc
03/04/2024	07:40	GlobeNewswire Inc.	Surrozen Publishes Study in 'Respiratory Research' Demonstrating the Promise of a Wnt Mimetic Antibody in Treating Pulmonary Fibrosis	NASDAQ:SRZN	Surrozen Inc
01/04/2024	07:30	GlobeNewswire Inc.	Surrozen Announces Safety, Pharmacodynamic and Liver Function Data for SZN-043	NASDAQ:SRZN	Surrozen Inc
01/04/2024	07:30	GlobeNewswire Inc.	Surrozen Announces up to $192.5 Million Private Placement of Securities Priced At-the-Market Under Nasdaq Rules	NASDAQ:SRZN	Surrozen Inc
07/02/2024	05:16	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:SRZN	Surrozen Inc
07/02/2024	05:10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SRZN	Surrozen Inc
18/01/2024	07:30	GlobeNewswire Inc.	Surrozen Provides Corporate Update on Clinical Programs	NASDAQ:SRZN	Surrozen Inc
18/12/2023	20:26	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SRZN	Surrozen Inc
08/11/2023	15:17	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:SRZN	Surrozen Inc
08/11/2023	15:05	GlobeNewswire Inc.	Surrozen Provides Third Quarter 2023 Financial Results	NASDAQ:SRZN	Surrozen Inc
24/10/2023	15:23	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:SRZN	Surrozen Inc
24/10/2023	15:18	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:SRZN	Surrozen Inc
13/10/2023	15:51	Edgar (US Regulatory)	Form PRE 14A - Other preliminary proxy statements	NASDAQ:SRZN	Surrozen Inc
23/08/2023	16:17	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:SRZN	Surrozen Inc
09/08/2023	15:05	GlobeNewswire Inc.	Surrozen Provides Second Quarter 2023 Financial Results	NASDAQ:SRZN	Surrozen Inc
05/06/2023	07:30	GlobeNewswire Inc.	Surrozen Publishes Study in Nature Communications Demonstrating the Promise of a Fzd4 Wnt Antibody in Treating Ischemic Stroke	NASDAQ:SRZN	Surrozen Inc
22/05/2023	08:35	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:SRZN	Surrozen Inc
10/05/2023	15:40	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:SRZN	Surrozen Inc
10/05/2023	15:05	GlobeNewswire Inc.	Surrozen Provides First Quarter 2023 Financial Results and Corporate and Pipeline Updates	NASDAQ:SRZN	Surrozen Inc
07/04/2023	16:21	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	NASDAQ:SRZN	Surrozen Inc
06/04/2023	16:25	Edgar (US Regulatory)	Annual Report to Security Holders (ars)	NASDAQ:SRZN	Surrozen Inc
06/04/2023	16:22	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:SRZN	Surrozen Inc
05/04/2023	15:20	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:SRZN	Surrozen Inc
05/04/2023	07:30	GlobeNewswire Inc.	Surrozen Strengthens Board of Directors with the Appointment of Eric Bjerkholt	NASDAQ:SRZN	Surrozen Inc
31/03/2023	15:53	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	NASDAQ:SRZN	Surrozen Inc
22/03/2023	15:01	GlobeNewswire Inc.	Surrozen Provides Fourth Quarter and Full Year 2022 Financial Results and Update on Clinical Pipeline and Corporate Progress	NASDAQ:SRZN	Surrozen Inc